• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Despite guidelines, pediatricians vary in antibiotic choice for pneumonia

byCordelia RossandKate Anderson
March 7, 2017
in Infectious Disease, Pediatrics, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The majority of children in outpatient clinics were prescribed a macrolide antibiotic for treatment of community acquired pneumonia (CAP) despite clear guidelines recommending amoxicillin in most cases.

2. Pediatrician antibiotic choice for CAP varied broadly by clinic and was influenced by both clinical and non-clinical factors.

Evidence rating level: 2 (Good)

 Study Rundown: Guidelines from the Pediatric Infectious Diseases Society of America 2011 recommend amoxicillin as the first-line agent for most cases of outpatient pediatric CAP to ensure appropriate coverage for Streptococcus pneumonia. Despite recommendations, there continues to be variability among pediatricians in antibiotic use for CAP. Researchers conducted a retrospective electronic health record (EHR) review of 31 pediatric primary care offices to identify factors influencing physicians’ prescribing patterns. Results showed more children were prescribed macrolides than amoxicillin to treat CAP in the outpatient setting even though >25% of S. pneumonia strains are resistant to this antibiotic class. Prescription choice was found to be influenced by both appropriate factors related to patient clinical presentation (e.g. age, previous antibiotic use) as well as nonclinical factors (e.g. insurance status, urban vs. rural practice setting). As a retrospective review, this study is limited by potential confounding variables influencing treatment choice that were not well documented in the EHR. Nonetheless, this data highlights the importance of understanding clinical and nonclinical factors that affect inappropriate antibiotic prescribing patterns in outpatient management of pediatric infections.

Click to read the study, published today in Pediatrics

Click to read the commentary, published today in Pediatrics

Relevant reading: Roles of Clinician, Patient, and Community Characteristics in the Management of Pediatric Upper Respiratory Tract Infections

RELATED REPORTS

The Scan by 2 Minute Medicine®: Overprescribed and Understocked, A Costly Message, A Bad Wrap and Mauna Loa Erupts Again!

The 2 Minute Medicine Podcast Episode 3

#VisualAbstract: Shorter antibiotic course non-inferior to longer course for pediatric community-acquired pneumonia

In-depth [retrospective cohort]: Study participants included 10 414 children aged 3 months to 18 years treated for CAP by a total of 196 physicians. These physicians practiced in 31 urban, suburban, and rural primary care practices in Pennsylvania and New Jersey from 2009 to 2013.Researchers collected EHR data on patient and provider demographics, practice setting, and patient medical history and clinical presentation to identify variables affecting antibiotic prescribing patterns. Results indicated that 42.5% of children were treated with macrolides, 40.1% received amoxicillin, and 16.8% received broad-spectrum antibiotics. Clinical factors associated with increased odds of macrolide prescription vs. amoxicillin included age ≥5 years (aOR: 6.18, 95% CI 5.53-6.91) and previous antibiotic exposures (aOR: 1.70; 95% CI 1.56-2.04), while decreased odds of macrolide prescription were associated with abnormal exam results (aOR: 0.80; 95% CI 0.66-0.97) and presence of fever (aOR: 0.44; 95% CI 0.37-0.53). These clinical factors help differentiate pneumococcal from atypical pneumonia and appropriately drive antibiotic choice. However, various nonclinical, sociodemographic factors also impacted the odds of macrolide vs. amoxicillin use. Private was associated with increased macrolide vs. amoxicillin prescription (aOR: 1.47; 95% CI 1.28-1.70), while >10 years of provider experience (aOR: 0.75; 95% CI 0.65-0.85) and patient race (aOR: 0.83; 95% CI (0.71-0.99) were associated with lower odds of macrolide vs. amoxicillin prescription.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: amoxicillinantibioticspneumonia
Previous Post

Children with disabilities at variable risk for maltreatment

Next Post

Imatinib safe and effective as long-term treatment for chronic myeloid leukemia: The IRIS trial

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Overprescribed and Understocked, A Costly Message, A Bad Wrap and Mauna Loa Erupts Again!

December 14, 2022
2MM Podcast

The 2 Minute Medicine Podcast Episode 3

February 9, 2023
#VisualAbstract: Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes
StudyGraphics

#VisualAbstract: Shorter antibiotic course non-inferior to longer course for pediatric community-acquired pneumonia

November 25, 2022
AAP recommends telemedicine to improve access to care
Emergency

Virtual pediatric acute care visits within the medical home are safe and acceptable to parents

November 25, 2022
Next Post
Imatinib safe and effective as long-term treatment for chronic myeloid leukemia: The IRIS trial

Imatinib safe and effective as long-term treatment for chronic myeloid leukemia: The IRIS trial

USPSTF finds insufficient evidence for screening for iron deficiency anemia during pregnancy

Treating subclinical hypothyroidism and hypothyroxinemia in pregnancy does not impact child IQ

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Ischemic stroke from cervical artery dissection associated with history of migraine

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
  • Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma
  • Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options